Injection Pen Market, by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global Injection Pen market size is projected to reach USD 53.4 billion by 2026 at a CAGR of 7.3% from USD 37.7 billion in 2021 during the forecast period 2021-2028.
Injection pen is an injectable device which is in the form of a pen. This device is used to deliver insulin (primarily) into the subcutaneous tissue of the body. This can be done by one on its own and thus reduce the dependency over doctors and others. The syringe is pushed by keeping it on the skin and is injected at an angle of 90 degree.
With the growing incidents of chronic cases along with the increased number of regulatory approvals required and the technological advancements in the sector are some of the factors that have supported long-term expansion for Injection Pen Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the injection pen market has not been significantly affected since the patients already using the pens continued with their usage although a supply chain crisis was observed along with marginal decline in trade during the lockdown.
North America is expected to be the largest market during the forecast period. Due to higher prevalent cases of diabetes and the favourable reimburse scenario has led to growth in the commercial refrigeration equipment in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 37.7 billion |
Growth Rate |
CAGR of 7.3% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Product type, therapy, end user and geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Novo Nordisk A/S, Becton, Dickinson and Company, Ypsomed Holding AG, Sanofi, Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford, Sulzer Ltd., Sun Pharmaceutical Industries Ltd., Pfizer, Biocon Ltd., Lupin Ltd., Wockhardt Ltd., AptarGroup, Inc., Novartis AG, Gerresheimer AG, Bespak Europe Ltd., SHL Medical AG, Boehringer Ingelhem, Nemera France SA, Companion Medical, and Jiangsu Delfu Medical Devices Co., Ltd. |
Available Customization |
In addition to the market data for Injection Pen Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Injection Pen Market is segmented into Product type, Therapy, End-User, and Geography.